Northern Trust Corp Albireo Pharma, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$18.01 - $23.78 $123,980 - $163,701	6,884 Added 3.89%	183,902 $3.97 Million
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $72,036 - $116,397	-4,414 Reduced 2.43%	177,018 $3.43 Million
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $58,308 - $117,277	-3,145 Reduced 1.7%	181,432 $3.6 Million
Q1 2022 May 13, 2022	SELL	$23.94 - $33.74 $140,479 - $197,986	-5,868 Reduced 3.08%	184,577 $5.51 Million
Q4 2021 Feb 08, 2022	SELL	$21.19 - $31.29 $95,058 - $140,366	-4,486 Reduced 2.3%	190,445 $4.44 Million
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $110,178 - $144,891	-4,027 Reduced 2.02%	194,931 $6.08 Million
Q2 2021 Aug 13, 2021	SELL	$28.9 - $36.87 $214,120 - $273,169	-7,409 Reduced 3.59%	198,958 $7 Million
Q1 2021 May 12, 2021	SELL	$32.03 - $42.85 $639,703 - $855,800	-19,972 Reduced 8.82%	206,367 $7.27 Million
Q4 2020 Feb 11, 2021	BUY	$31.56 - $42.16 $967,598 - $1.29 Million	30,659 Added 15.67%	226,339 $8.49 Million
Q3 2020 Nov 16, 2020	SELL	$23.19 - $41.61 $56,235 - $100,904	-2,425 Reduced 1.22%	195,680 $6.53 Million
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $333,464 - $673,229	22,501 Added 12.81%	198,105 $5.25 Million
Q1 2020 May 14, 2020	BUY	$11.67 - $27.23 $302,404 - $705,610	25,913 Added 17.31%	175,604 $2.87 Million
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $710 - $1,216	42 Added 0.03%	149,691 $3.81 Million
Q3 2019 Nov 13, 2019	BUY	$20.0 - $31.88 $595,120 - $948,621	29,756 Added 24.82%	149,649 $2.99 Million
Q2 2019 Aug 13, 2019	BUY	$30.67 - $37.86 $80,692 - $99,609	2,631 Added 2.24%	119,893 $3.87 Million
Q1 2019 May 13, 2019	BUY	$22.22 - $32.21 $79,303 - $114,957	3,569 Added 3.14%	117,262 $3.78 Million
Q4 2018 Feb 12, 2019	SELL	$20.9 - $32.57 $543 - $846	-26 Reduced 0.02%	113,693 $2.79 Million
Q3 2018 Nov 14, 2018	BUY	$29.29 - $36.87 $407,131 - $512,492	13,900 Added 13.93%	113,719 $3.75 Million
Q2 2018 Sep 18, 2018	BUY	$28.9 - $37.31 $133,229 - $171,999	4,610 Added 4.84%	99,819 $3.54 Million
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $2.3 Million - $2.96 Million	79,443 Added 503.89%	95,209 $3.38 Million
Q1 2018 May 09, 2018	BUY	$26.78 - $39.35 $158,858 - $233,424	5,932 Added 60.32%	15,766 $513,000
Q4 2017 Feb 14, 2018	BUY	$21.56 - $28.14 $212,021 - $276,728	9,834	9,834 $252,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account